Citadel Advisors’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,856
| Closed | -$64.7K | – | 6171 |
|
|
2024
Q3 | $64.7K | Buy |
+12,856
| New | +$64.7K | ﹤0.01% | 5046 |
|
|
2024
Q1 | – | Sell |
-14,005
| Closed | -$117K | – | 6263 |
|
|
2023
Q4 | $117K | Sell |
14,005
-2,201
| -14% | -$18.4K | ﹤0.01% | 4822 |
|
|
2023
Q3 | $137K | Buy |
+16,206
| New | +$137K | ﹤0.01% | 4704 |
|
|
2022
Q4 | – | Sell |
-1,468
| Closed | -$14K | – | 6193 |
|
|
2022
Q3 | $14K | Sell |
1,468
-4,548
| -76% | -$43.4K | ﹤0.01% | 5588 |
|
|
2022
Q2 | $69K | Buy |
+6,016
| New | +$69K | ﹤0.01% | 5414 |
|
|
2021
Q3 | – | Sell |
-2,386
| Closed | -$311K | – | 6538 |
|
|
2021
Q2 | $311K | Sell |
2,386
-1,110
| -32% | -$145K | ﹤0.01% | 5168 |
|
|
2021
Q1 | $631K | Buy |
+3,496
| New | +$631K | ﹤0.01% | 4362 |
|